Trace Biosciences Inc. funding
Trace Biosciences Inc., a biotechnology company based in Beaverton, OR (founded 2021), filed a Form D with the SEC on August 12, 2026 and reported $8.3M raised of a $16.2M offering.
Amount raised$8.3M
Offering size$16.2M
Filed with the SECAugust 12, 2026
First saleJuly 28, 2026
IndustryBiotechnology
SecuritiesEquity
LocationBeaverton, OR
Founded2021
Entity typeCorporation
Investors so far19
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 12